Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Aditya Madiraju went from a high-paying finance job to walking in Paris Fashion Week and filming beauty content for his 5 million followers across platforms fernando-rodriguez Aditya Madiraju started ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

📚 Master data structures in Java with detailed analyses, practical examples, and clear trade-offs to enhance your programming skills.

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Filmmaker Aditya Dhar is currently leading the headlines after the trailer of his latest film, Dhurandhar, created huge excitement among his fans. A spy-action thriller starring Ranveer Singh, Sanjay ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Shafali was named the Player of the Match for her efforts, and she enjoyed her performance. Shafali Verma was magnificent with the bat and ball in the Women’s World Cup final against South Africa.

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

After moving from Arizona to Matthew Perry’s last house, real-estate scion Anita Verma-Lallian has a dream: Cashing in on data-center mania to fund her own mega-studio. By Steven Zeitchik Senior ...